Daniel Loeb - Third Point
Holding/activity history for Ligand Pharmaceuticals Inc Cl B (LGDG)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2010 Q4 | 0 | 0.00 | Sell 100.00% | 0.51 | SEC | ||
| 2010 Q3 | 2,007,378 | 0.51 | $1.58 | $3,172,000 | SEC | ||
| 2010 Q2 | 2,007,378 | 0.60 | $1.46 | $2,931,000 | SEC | ||
| 2010 Q1 | 2,007,378 | 0.46 | $1.74 | $3,493,000 | SEC | ||
| 2009 Q4 | 2,007,378 | 1.15 | $2.17 | $4,356,000 | SEC | ||
| 2009 Q3 | 2,007,378 | 0.54 | $2.31 | $4,637,000 | SEC | ||
| 2009 Q2 | 2,007,378 | 0.74 | $2.86 | $5,741,000 | SEC | ||
| 2009 Q1 | 2,007,378 | 1.49 | $2.98 | $5,982,000 | SEC | ||
| 2008 Q4 | 2,007,378 | 0.91 | $2.74 | $5,500,000 | SEC | ||
| 2008 Q3 | 2,007,378 | 0.54 | $2.95 | $5,922,000 | SEC | ||
| 2008 Q2 | 2,007,378 | 0.21 | $2.60 | $5,219,000 | SEC | ||
| 2008 Q1 | 2,007,378 | 0.31 | $4.00 | $8,030,000 | SEC | ||
| 2007 Q4 | 2,007,378 | 0.35 | Add 0.12% | <0.01 | $4.83 | $9,696,000 | SEC |
| 2007 Q3 | 2,005,000 | 0.29 | $5.34 | $10,707,000 | SEC | ||
| 2007 Q2 | 2,005,000 | 0.36 | $6.88 | $13,794,000 | SEC | ||
| 2007 Q1 | 2,005,000 | 0.82 | Reduce 74.05% | 3.04 | $10.08 | $20,210,000 | SEC |
| 2006 Q4 | 7,725,000 | 4.10 | Add 4.75% | 0.19 | $10.95 | $84,589,000 | SEC |
| 2006 Q3 | 7,375,000 | 5.25 | $10.04 | $74,045,000 | SEC | ||
| 2006 Q2 | 7,375,000 | 4.53 | $8.45 | $62,319,000 | SEC | ||
| 2006 Q1 | 7,375,000 | 5.10 | $12.85 | $94,769,000 | SEC | ||
| 2005 Q4 | 7,375,000 | 4.54 | Add 5.36% | 0.23 | $11.15 | $82,231,000 | SEC |
| 2005 Q3 | 7,000,000 | 2.47 | Buy | 2.47 | $10.14 | $70,959,000 | SEC |